Article Information
History
- May 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Åse Garløv Riis1,*,
- Tonje Merethe Røssland2,
- Iren Høyland Löhr2,
- Ingvild Dalen3,
- Lars Kåre Kleppe1,
- Jon Sundal1,
- Åse Berg1,
- May Sissel Vadla4,6,
- Ole Bernt Lenning5,6 and
- Heidi Syre2
- 1Division of Medicine, Stavanger University Hospital, Stavanger, Norway
- 2Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway
- 3Department of Research, Section of Biostatistics (I.D.), Stavanger University Hospital Stavanger, Norway
- 4Faculty of health science, University of Stavanger, Norway
- 5Research Department, Stavanger University Hospital, Stavanger, Norway
- 6Municipality of Randaberg, Stavanger, Norway
- ↵*Corresponding author:
Åse Garløv Riis, Division of Medicine, Stavanger University Hospital, Stavanger, Norway. University Hospital, PO box 8100, 4068 Stavanger, Norway. Phone: 0047 51513732. Fax: 0047 51519939. Email corresponding author ase.garlov.riis{at}gmail.com
Posted May 19, 2022.
Clinical validation of 3D-printed nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 RT-PCR
